These compounds may interact with:
Probable global transcription activator SNF2L2
Potentially involved in: intellectual disability; hypotrichosis; kidney cancer; carcinoma; liver cancer; schimke immuno-osseous dysplasia; dental caries; coffin-siris syndrome; gingivitis; alpha thalassemia; cockayne syndrome; enamel erosion; spondyloepiphyseal dysplasia with congenital joint dislocations; cancer; aggressive behavior; cryptorchidism; adenoid cystic carcinoma; epilepsy; fetal growth retardation; infant, small for gestational age
Disease data sourced from Pharos.